Ricoh USA has sold Ricoh 3D for Healthcare to Myrava, Inc., a company focused on providing access to personalised medical devices and healthcare innovations across the United States.
The Ricoh 3D for Healthcare patient‑specific medical device business was launched in 2025, after previously operating as an internal 3D medical manufacturing centre.
Ricoh's decision is said to reflect its 'continued efforts to sharpen its strategic focus on process automation, workplace experience, and business process services,' and a prioritisation on investments in scalable businesses that 'align most closely with its primary mission and strengths.'
“While healthcare remains a key growth area for Ricoh, patient‑specific medical devices require specialised capabilities that extend beyond the scope of our broader business priorities,” said Bob Lamendola, Chief Digital Services and Delivery Officer, Ricoh USA, Inc. “This move enables the business to scale under dedicated ownership, while allowing Ricoh to concentrate on the areas where we deliver the greatest value - helping healthcare providers reduce cost and administrative burden, facilitate regulatory compliance, improve operational efficiency, and measurably support better patient and clinician experiences through our scalable, reliable services and technology.”
“Ricoh took an important step last year by establishing Ricoh 3D for Healthcare, LLC as a standalone entity, creating the focus and structure needed to serve a highly specialised and rapidly growing market,” said Gary Turner, CEO of Myrava, Inc. and formerly Vice President and General Manager of Ricoh 3D for Healthcare, LLC. “This acquisition is a natural next step in that evolution. As an independent company, Myrava, Inc. will benefit from dedicated investment and leadership fully focused on advancing personalised, FDA‑cleared medical devices and point‑of‑care manufacturing for healthcare providers.”
